Literature DB >> 25649977

Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.

XueLian Li1, SaiHua Zheng, ShangJie Chen, Feng Qin, Sandy Lau, Qi Chen.   

Abstract

The incidence and the trend of gynaecological cancers have been suggested to vary by ethnicity and geographical regions. Whether the incidence and type of gynaecological cancers in China is different have not been fully investigated. In this study, we reported the trend of gynaecological cancers in China. Data on 13,518 women with gynaecological cancers were collected from the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Data included age at diagnosis and the annual number of women with diagnosed endometrial, ovarian, cervical cancer and other gynaecological cancers. The number of women with diagnosed gynaecological cancers increased by almost sixfold in 2013 compared to that in 2003. It was largely due to the increase of women with newly diagnosed cervical cancer. The percentage of women with endometrial and ovarian cancer within total gynaecological cancers was decreased, whilst the percentage of cervical cancer significantly increased between 2003 and 2013. The mean age of women with endometrial or ovarian cancer at diagnosis was 53 or 48 years, respectively, which was no difference over 11 years. However, the mean age of women with cervical cancer at diagnosis was significantly delayed from 42 years in 2003 to 46 years since 2011. This was also confirmed by the age-specific distribution of gynaecological cancers over 11 years. Our study found that the age onset of endometrial and ovarian cancer has not changed over 11 years. But the age onset of cervical cancer is delayed since 2011 in China.

Entities:  

Mesh:

Year:  2015        PMID: 25649977     DOI: 10.1007/s13277-015-3143-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  14 in total

1.  Endometrial cancer survival among U.S. black and white women by birth cohort.

Authors:  Linda S Cook; Leanne M Kmet; Anthony M Magliocco; Noel S Weiss
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

Review 2.  Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

Authors:  Edward P Armstrong
Journal:  J Manag Care Pharm       Date:  2010-04

3.  Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; E Preti; F Landoni; S Carinelli; A Colombo; C Marini; C Sessa
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

4.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

Authors:  Brenda K Edwards; Martin L Brown; Phyllis A Wingo; Holly L Howe; Elizabeth Ward; Lynn A G Ries; Deborah Schrag; Patricia M Jamison; Ahmedin Jemal; Xiao Cheng Wu; Carol Friedman; Linda Harlan; Joan Warren; Robert N Anderson; Linda W Pickle
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

5.  The impact of race and comorbidity on survival in endometrial cancer.

Authors:  Sara H Olson; Coral L Atoria; Michele L Cote; Linda S Cook; Radhai Rastogi; Robert A Soslow; Carol L Brown; Elena B Elkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

6.  Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.

Authors:  Patricia M Jamison; Anne-Michelle Noone; Lynn A G Ries; Nancy C Lee; Brenda K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-12       Impact factor: 4.254

7.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

8.  Endometrial cancer in Asian and American Indian/Alaskan Native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women.

Authors:  Haider Mahdi; Cary Jo Schlick; Li-Lian Kowk; Mehdi Moslemi-Kebria; Chad Michener
Journal:  Gynecol Oncol       Date:  2013-12-03       Impact factor: 5.482

9.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 10.  Adjuvant chemotherapy for advanced endometrial cancer.

Authors:  Khadra Galaal; Mansour Al Moundhri; Andrew Bryant; Alberto D Lopes; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2014-05-15
View more
  11 in total

1.  H19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition.

Authors:  Le Zhao; Zhen Li; Wei Chen; Wen Zhai; Jingjing Pan; Huan Pang; Xu Li
Journal:  Oncol Lett       Date:  2016-11-16       Impact factor: 2.967

2.  Histopathology of women with non-uniform endometrial echogenicity and risk factors for atypical endometrial hyperplasia and carcinoma.

Authors:  Qing Cong; Lingxiao Luo; Zhongpeng Fu; Jiaqi Lu; Wei Jiang; Long Sui
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause.

Authors:  Yifei Gao; Xujing Dai; Limei Chen; Arier C Lee; Mancy Tong; Michelle Wise; Qi Chen
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

4.  Narrowing Resection of Parametrial Tissues Is Feasible in Low-Risk Cases of Stage IA2-IB1 Cervical Cancer.

Authors:  Xue-Lian Li; Xiao-Xia Liu; Guan-Shu Cao; Dan-Dan Ju; Hua Jiang
Journal:  J Cancer       Date:  2016-07-05       Impact factor: 4.207

5.  Effect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro.

Authors:  Hang-Zhi Gu; Rong-Rong Lin; Han-Chu Wang; Xue-Jie Zhu; Yan Hu; Fei-Yun Zheng
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

Review 6.  Clinical significance of matrix metalloproteinase-2 in endometrial cancer: A systematic review and meta-analysis.

Authors:  Chang Liu; Ying Li; Shasha Hu; Yao Chen; Li Gao; Dajiang Liu; Hongtao Guo; Yongxiu Yang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females.

Authors:  Junhong Cai; Siyuan Peng; Haibo Wang; Shan Bao
Journal:  Pharmgenomics Pers Med       Date:  2022-04-07

8.  Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.

Authors:  Xi Zeng; Zhu Zhang; Qian-Qian Gao; Yan-Yun Wang; Xiu-Zhang Yu; Bin Zhou; Ming-Rong Xi
Journal:  Dis Markers       Date:  2016-05-31       Impact factor: 3.434

9.  Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1.

Authors:  Yuan Yang; Jingyi Zhou; Xiaoping Li; Lijun Zhao; Yuan Cheng; Yanying Lin; Jiaqi Wang; Lihui Wei; Yafeng Dong; Jianliu Wang
Journal:  Oncotarget       Date:  2017-12-15

10.  The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women.

Authors:  Fang Shen; Shouzhen Chen; Yifei Gao; Xujing Dai; Qi Chen
Journal:  Oncotarget       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.